Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2026-01-04 @ 4:20 PM
Study NCT ID:
NCT00528567
Status:
COMPLETED
Last Update Posted:
2015-09-04
First Post:
2007-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-11
First Submit QC Date:
None
Study First Post Date:
2007-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-02-28
Results First Submit QC Date:
None
Results First Post Date:
2013-09-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-05
Last Update Post Date:
2015-09-04
Last Update Post Date Type:
ESTIMATED